Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
iQIYI $442 million follow-on offering
We advised the issuer on a follow-on offering of ADSs
Jinxin Fertility Group HK$1.17 billion top-up placement of shares
The shares are listed on the Hong Kong Stock Exchange
Expro $151.8 million secondary offering
The shares are listed on the NYSE
Cactus $172.5 million follow-on offering
We advised Cactus on the stock offering
Bilibili convertible notes exchange and concurrent follow-on equity offering
The transaction involved a convertible notes exchange and a concurrent follow-on offering of ADSs
Tellurian $500 million at-the-market offering
The shares are listed on the NYSE
Gaming and Leisure Properties $1 billion at-the-market offering
The shares are listed on Nasdaq
Terns Pharmaceuticals $86 million stock offering
The stock is listed on the Nasdaq Global Select Market
Coherus BioSciences $150 million at-the-market offering
The stock is listed on the Nasdaq Global Market